Literature DB >> 15234108

Inhibition of mitochondrial creatine kinase activity from rat cerebral cortex by methylmalonic acid.

P F Schuck1, R B Rosa, L F Pettenuzzo, A Sitta, C M D Wannmacher, A T S Wyse, M Wajner.   

Abstract

Accumulation of methylmalonic acid (MMA) in tissues and biological fluids is the biochemical hallmark of patients affected by the neurometabolic disorder known as methylmalonic acidemia (MMAemia). Although this disease is predominantly characterized by severe neurological findings, the underlying mechanisms of brain injury are not totally established. In the present study, we investigated the effect of MMA, as well as propionic (PA) and tiglic (TA) acids, whose concentrations are also increased but to a lesser extend in MMAemia, on total (tCK), cytosolic (Cy-CK) and mitochondrial (Mi-CK) creatine kinase (CK) activities from cerebral cortex of 30-day-old Wistar rats. Total CK activity (tCK) was measured in whole cell homogenates, whereas Cy-CK and Mi-CK were determined, respectively, in cytosolic and mitochondrial preparations from rat cerebral cortex. We verified that tCK and Mi-CK activities were significantly inhibited by MMA at concentrations as low as 1 mM, in contrast to Cy-CK which was not affected by the presence of the acid in the incubation medium. Furthermore, PA and TA, at concentrations as high as 5 mM, did not alter CK activity. We also observed that the inhibitions provoked by MMA were fully prevented by pre-incubation of the homogenates with reduced glutathione, suggesting that the inhibitory effect of MMA was possibly mediated by oxidation of essential thiol groups of the enzyme. Considering the importance of CK for brain metabolism homeostasis, our results suggest that inhibition of this enzyme by increased levels of MMA may contribute to the neurodegeneration of patients affected by MMAemia and explain previous reports showing an impairment of brain energy metabolism and a reduction of brain phosphocreatine levels caused by MMA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15234108     DOI: 10.1016/j.neuint.2004.03.006

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  15 in total

Review 1.  Mitochondrial energy metabolism in neurodegeneration associated with methylmalonic acidemia.

Authors:  Daniela R Melo; Alicia J Kowaltowski; Moacir Wajner; Roger F Castilho
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.

Authors:  Cláudia Funchal; Patrícia Fernanda Schuck; André Quincozes Dos Santos; Maria Caroline Jacques-Silva; Carmem Gottfried; Regina Pessoa-Pureur; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

3.  Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.

Authors:  Graziela S Ribas; Giovana B Biancini; Caroline Mescka; Carlos Y Wayhs; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-07-22       Impact factor: 5.046

4.  Lactate dehydrogenase activity is inhibited by methylmalonate in vitro.

Authors:  Laura O Saad; Sandra R Mirandola; Evelise N Maciel; Roger F Castilho
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

5.  A new role of glucose-6-phosphate isomerase: protection of cell structures from malonic dialdehyde.

Authors:  Z S Agadzhanyan; L F Dmitriev
Journal:  Dokl Biochem Biophys       Date:  2005 Jul-Aug       Impact factor: 0.788

6.  Decreased creatine kinase activity caused by electroconvulsive shock.

Authors:  Márcio Búrigo; Clarissa A Roza; Cintia Bassani; Gustavo Feier; Felipe Dal-Pizzol; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

7.  Isovaleric, methylmalonic, and propionic acid decrease anesthetic EC50 in tadpoles, modulate glycine receptor function, and interact with the lipid 1,2-dipalmitoyl-Sn-glycero-3-phosphocholine.

Authors:  Yun Weng; Tienyi Theresa Hsu; Jing Zhao; Stefanie Nishimura; Gerald G Fuller; James M Sonner
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

Review 8.  Metabolic disturbances in diseases with neurological involvement.

Authors:  João M N Duarte; Patrícia F Schuck; Gary L Wenk; Gustavo C Ferreira
Journal:  Aging Dis       Date:  2013-11-30       Impact factor: 6.745

9.  Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle.

Authors:  Alethea G Barschak; Gustavo da C Ferreira; Karina R André; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Carlos S Dutra Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2006-04-28       Impact factor: 3.584

10.  Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure.

Authors:  André C Affonso; Daniele G Machado; Fernanda Malgarin; Daiane B Fraga; Fernando Ghedim; Alexandra Zugno; Emílio L Streck; Patrícia F Schuck; Gustavo C Ferreira
Journal:  Metab Brain Dis       Date:  2013-03-09       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.